Agency Information Collection Activities: Proposed Collection; Comment Request, 30172-30174 [2011-12505]

Download as PDF 30172 Federal Register / Vol. 76, No. 100 / Tuesday, May 24, 2011 / Notices EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued Maximum number of respondents Interview type Total .......................................................................................................... Total burden hours 120 Average hourly wage rate* 147 NA Total cost burden 7,454 * The hourly wage for the participants across the four data collections (screening questionnaire, needs assessment interview, usability testing interviews, and discussion group interviews) is based upon the mean of the average hourly wages for Social science research assistants (19– 4061; $19.39 per hour); Postsecondary Health Specialties Teachers (25–1071; $53.88 per hour);Management analysts (13–1111; $40.70 per hour); Computer and Information Systems Managers (11–3021; $58.00 per hour); Family and General Practitioners Teachers (29–1060; $81.03 per hour);Pharmacists (29–1051; $51.27 per hour). May 2009 National Occupational Employment and Wage Estimates, United States, U.S. Bureau of Labor Statistics Division of Occupational Employment Statistics http://www.bls.gov/oes/current/oes_nat.htm#29–0000. Estimated Annual Costs to the Federal Government The estimated total cost to the Federal Government for this project is $411,641.00 over a two-year period from September 8, 2010 to September 7, 2012. The estimated average annual cost is $205,821. Exhibit 3 provides a breakdown of the estimated total and average annual costs by category. EXHIBIT 3—ESTIMATED TOTAL AND ANNUAL COST * TO THE FEDERAL GOVERNMENT Cost component Total cost Annualized cost Project Management and Coordination Activities ................................................................................................... Evaluation Plan and Protocol Development ............................................................................................................ OMB Submission Package ...................................................................................................................................... Conduct Evaluation ** .............................................................................................................................................. Data Analysis, Report and Briefing ......................................................................................................................... Documentation and 508 Compliance ...................................................................................................................... $58,140 44,908 12,362 159,991 118,081 18,159 $29,070 22,454 6,181 79,996 59,041 9,080 Total .................................................................................................................................................................. 411,641 205,821 * Costs are fully loaded including overhead, G&A and fees. ** These activities include the data collections described in this submission. jlentini on DSK4TPTVN1PROD with NOTICES Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ healthcare research and healthcare information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. VerDate Mar<15>2010 16:47 May 23, 2011 Jkt 223001 Dated: May 10, 2011. Carolyn M. Clancy, Director. [FR Doc. 2011–12506 Filed 5–23–11; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Comment Request Agency for Healthcare Research and Quality, HHS. ACTION: Notice. AGENCY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project: ‘‘Pilot Test of the Proposed Pharmacy Survey on Patient Safety Culture.’’ In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501–3521, AHRQ invites the public to comment on this proposed information collection. This proposed information collection was previously published in the Federal SUMMARY: PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Register on March 11th, 2011 and allowed 60 days for public comment. One comment was received. The purpose of this notice is to allow an additional 30 days for public comment. DATES: Comments on this notice must be received by June 23, 2011. ADDRESSES: Written comments should be submitted to: AHRQ’s OMB Desk Officer by fax at (202) 395–6974 (attention: AHRQ’s desk officer) or by email at OIRA_submission@omb.eop.gov (attention: AHRQ’s desk officer). Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from the AHRQ Reports Clearance Officer. FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by e-mail at doris.lefkowitz@ AHRQ.hhs.gov. SUPPLEMENTARY INFORMATION: Proposed Project Pilot Test of the Proposed Pharmacy Survey on Patient Safety Culture As the baby boomer population ages, the general U.S. population continues to grow, and as drug therapies for the treatment of chronic diseases become more efficacious, the expected increase E:\FR\FM\24MYN1.SGM 24MYN1 30173 Federal Register / Vol. 76, No. 100 / Tuesday, May 24, 2011 / Notices in the number of prescriptions and demand for pharmaceutical products is likely to increase the potential for medication errors in community/retail pharmacies. In 2007, there were about 56,000 community/retail pharmacies, including about 22,000 traditional chain pharmacy companies, nearly 17,000 independent drug stores, about 9,300 supermarket pharmacies, and about 7,700 mass merchant pharmacies. Numerous reports substantiate the presence of medication errors in pharmacies. For example, one national observational study of prescription dispensing accuracy and safety in 50 pharmacies in the U.S. found a rate of about 4 errors per day in a pharmacy filling 250 prescriptions daily. This error rate translates to an estimated 51.5 million errors occurring during the filling of 3 billion prescriptions each year. Given the widespread impact of pharmacies on patient safety, the new Pharmacy Survey on Patient Safety Culture (Pharmacy SOPS) will measure pharmacy staff perceptions about what is important in their organization and what attitudes and behaviors related to patient safety are supported, rewarded, and expected. The survey will help community/retail pharmacies to identify and discuss strengths and weaknesses of patient safety culture within their individual pharmacies. They can then use that knowledge to develop appropriate action plans to improve their practices and their culture of patient safety. This survey is designed for use in community/retail pharmacies, which includes chain drugstores (e.g., Walgreens and CVS), supermarket pharmacies, independently owned pharmacies, and mass merchant pharmacies (e.g., Wal-Mart, Costco, Target), not for use in hospital pharmacies. This research has the following goals: (1) Cognitively test and modify as necessary the Pharmacy Survey on Patient Safety Culture Questionnaire; (2) Pretest and modify the questionnaire as necessary; (3) Make the final questionnaire available to the public. This study is being conducted by AHRQ through its contractor, Westat, pursuant to AHRQ’s statutory authority to conduct and support research on healthcare and on systems for the delivery of such care, including activities with respect to the quality, effectiveness, efficiency, appropriateness and value of healthcare services and with respect to quality measurement and improvement. 42 U.S.C. 299a(a)(1) and (2). Method of Collection To achieve the goals of this study the following activities and data collections will be implemented: (1) Cognitive interviews—Two rounds of interviews will be conducted by telephone with 10 respondents each. The purpose of these interviews is to refine the questionnaire’s items and composites. Each round will be conducted with a mix of pharmacists and non-pharmacist staff working in community/retail pharmacies throughout the U.S. The same interview guide will be used for each round. (2) Pretest—The draft questionnaire will be pretested with all pharmacy staff in approximately 60 community/retail pharmacies. The purpose of the pretest is to collect data for an assessment of the reliability and construct validity of the survey’s items and composites, allowing for their further refinement. (3) Pharmacy background questionnaire—This questionnaire will be completed by the pharmacy manager in each of the 60 pretest sites to provide background characteristics of the pharmacy, such as pharmacy type (independently owned or chain), type of chain (traditional drugstore, supermarkets, mass merchant), average number of prescriptions filled weekly, average number of hours the pharmacy is open on weekdays, etc. (4) Dissemination activities—The final questionnaire will be made available to the public through the AHRQ website. This activity does not impose a burden on the public and is therefore not included in the burden estimates in Exhibit 1. The information collected will be used to test and improve the draft survey items in the Pharmacy Survey on Patient Safety Culture Questionnaire. Psychometric analysis will be conducted on the pilot data to examine item nonresponse, item response variability, factor structure, reliability, and construct validity of the items included in the survey. Because the survey items are being developed to measure specific aspects of patient safety culture in the pharmacy setting, the factor structure of the survey items will be evaluated through multilevel confirmatory factor analysis. On the basis of the data analyses, items or factors may be dropped. Estimated Annual Respondent Burden Exhibit 1 shows the estimated annualized burden hours for the pharmacies’ time to participate in this research. Cognitive interviews will be conducted with staff at 20 pharmacies (approximately 10 pharmacists and 10 nonpharmacist staff) and will take about one hour and 30 minutes to complete. 627 staff from 60 pharmacies will participate in the pretest (an average of 10.45 staff from each pharmacy). The pretest questionnaire (the Pharmacy Survey on Patient Safety Culture) requires 15 minutes to complete. The pharmacy background questionnaire will be completed by the manager at each of the 60 pharmacies participating in the pretest and takes 10 minutes to complete. The total annualized burden is estimated to be 197 hours. Exhibit 2 shows the estimated annualized cost burden associated with the pharmacies’ time to participate in this research. The total cost burden is estimated to be $4,948 annually. EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS Number of pharmacies Form Name/activity Number of responses per pharmacy Hours per response Total burden hours jlentini on DSK4TPTVN1PROD with NOTICES Cognitive interviews ......................................................................................... Pretest .............................................................................................................. Pharmacy background questionnaire .............................................................. 20 60 60 1 10.45 1 1.5 15/60 10/60 30 157 10 Total .......................................................................................................... 140 na na 197 VerDate Mar<15>2010 16:47 May 23, 2011 Jkt 223001 PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 E:\FR\FM\24MYN1.SGM 24MYN1 30174 Federal Register / Vol. 76, No. 100 / Tuesday, May 24, 2011 / Notices EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Number of pharmacies Form Name/activity Total burden hours Average hourly wage rate * Total cost burden Cognitive interviews ......................................................................................... Pretest .............................................................................................................. Pharmacy background questionnaire .............................................................. 20 60 60 30 157 10 $32.28 22.08 51.27 $968 3,467 513 Total .......................................................................................................... 140 197 na $4,948 * Based upon the mean of the average hourly wages for Pharmacists (29–1051; $51.27), Pharmacy Technicians (29–2052; $13.92), and Pharmacy Aides (31–9095; $10.74), National Compensation Survey: Occupational wages in the United States May 2009, ‘‘U.S. Department of Labor, Bureau of Labor Statistics.’’ The hourly wage for the cognitive interviews is a weighted average for 10 pharmacists, 8 pharmacy technicians and 2 pharmacy aides; the hourly wage for the pretest is a weighted average for 157 pharmacists, 235 pharmacy technicians and 235 pharmacy aides. Estimated Annual Costs to the Federal Government Exhibit 3 shows the estimated total and annualized cost for this project. Although data collection will last for less than one year, the entire project will take about 3 years. The total cost for this project is approximately $320,818. EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST Cost component Total cost Annualized cost Project Development ............................................................................................................................................... Data Collection Activities ......................................................................................................................................... Data Processing and Analysis ................................................................................................................................. Publication of Results .............................................................................................................................................. Project Management ................................................................................................................................................ Overhead ................................................................................................................................................................. $65,340 62,831 11,004 15,767 7,496 158,380 $21,780 20,944 3,368 5,256 2,498 5,293 Total .................................................................................................................................................................. 320,818 106,939 jlentini on DSK4TPTVN1PROD with NOTICES Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: 0(a) Whether the proposed collection of information is necessary for the proper performance of AHRQ healthcare research and healthcare information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. VerDate Mar<15>2010 16:47 May 23, 2011 Jkt 223001 Dated: May 10, 2011. Carolyn M. Clancy, Director. [FR Doc. 2011–12505 Filed 5–23–11; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Interagency Committee on Smoking and Health: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Interagency Committee on Smoking and Health, Department of Health and Human Services, has been renewed for a 2-year period through March 20, 2013. For information, contact Dana Shelton, Designated Federal Officer, Interagency Committee on Smoking and Health, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, M/S K–50, Atlanta, Georgia 30333, telephone 770/488–5709 or fax 770/ 488–5767. PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 11, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–12568 Filed 5–23–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated E:\FR\FM\24MYN1.SGM 24MYN1

Agencies

[Federal Register Volume 76, Number 100 (Tuesday, May 24, 2011)]
[Notices]
[Pages 30172-30174]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-12505]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the intention of the Agency for 
Healthcare Research and Quality (AHRQ) to request that the Office of 
Management and Budget (OMB) approve the proposed information collection 
project: ``Pilot Test of the Proposed Pharmacy Survey on Patient Safety 
Culture.'' In accordance with the Paperwork Reduction Act, 44 U.S.C. 
3501-3521, AHRQ invites the public to comment on this proposed 
information collection.
    This proposed information collection was previously published in 
the Federal Register on March 11th, 2011 and allowed 60 days for public 
comment. One comment was received. The purpose of this notice is to 
allow an additional 30 days for public comment.

DATES: Comments on this notice must be received by June 23, 2011.

ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk 
Officer by fax at (202) 395-6974 (attention: AHRQ's desk officer) or by 
e-mail at OIRA_submission@omb.eop.gov (attention: AHRQ's desk 
officer).
    Copies of the proposed collection plans, data collection 
instruments, and specific details on the estimated burden can be 
obtained from the AHRQ Reports Clearance Officer.

FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports 
Clearance Officer, (301) 427-1477, or by e-mail at 
doris.lefkowitz@AHRQ.hhs.gov.

SUPPLEMENTARY INFORMATION:

Proposed Project

Pilot Test of the Proposed Pharmacy Survey on Patient Safety Culture

    As the baby boomer population ages, the general U.S. population 
continues to grow, and as drug therapies for the treatment of chronic 
diseases become more efficacious, the expected increase

[[Page 30173]]

in the number of prescriptions and demand for pharmaceutical products 
is likely to increase the potential for medication errors in community/
retail pharmacies. In 2007, there were about 56,000 community/retail 
pharmacies, including about 22,000 traditional chain pharmacy 
companies, nearly 17,000 independent drug stores, about 9,300 
supermarket pharmacies, and about 7,700 mass merchant pharmacies. 
Numerous reports substantiate the presence of medication errors in 
pharmacies. For example, one national observational study of 
prescription dispensing accuracy and safety in 50 pharmacies in the 
U.S. found a rate of about 4 errors per day in a pharmacy filling 250 
prescriptions daily. This error rate translates to an estimated 51.5 
million errors occurring during the filling of 3 billion prescriptions 
each year.
    Given the widespread impact of pharmacies on patient safety, the 
new Pharmacy Survey on Patient Safety Culture (Pharmacy SOPS) will 
measure pharmacy staff perceptions about what is important in their 
organization and what attitudes and behaviors related to patient safety 
are supported, rewarded, and expected. The survey will help community/
retail pharmacies to identify and discuss strengths and weaknesses of 
patient safety culture within their individual pharmacies. They can 
then use that knowledge to develop appropriate action plans to improve 
their practices and their culture of patient safety. This survey is 
designed for use in community/retail pharmacies, which includes chain 
drugstores (e.g., Walgreens and CVS), supermarket pharmacies, 
independently owned pharmacies, and mass merchant pharmacies (e.g., 
Wal-Mart, Costco, Target), not for use in hospital pharmacies.
    This research has the following goals:
    (1) Cognitively test and modify as necessary the Pharmacy Survey on 
Patient Safety Culture Questionnaire;
    (2) Pretest and modify the questionnaire as necessary;
    (3) Make the final questionnaire available to the public.
    This study is being conducted by AHRQ through its contractor, 
Westat, pursuant to AHRQ's statutory authority to conduct and support 
research on healthcare and on systems for the delivery of such care, 
including activities with respect to the quality, effectiveness, 
efficiency, appropriateness and value of healthcare services and with 
respect to quality measurement and improvement. 42 U.S.C. 299a(a)(1) 
and (2).

Method of Collection

    To achieve the goals of this study the following activities and 
data collections will be implemented:
    (1) Cognitive interviews--Two rounds of interviews will be 
conducted by telephone with 10 respondents each. The purpose of these 
interviews is to refine the questionnaire's items and composites. Each 
round will be conducted with a mix of pharmacists and non-pharmacist 
staff working in community/retail pharmacies throughout the U.S. The 
same interview guide will be used for each round.
    (2) Pretest--The draft questionnaire will be pretested with all 
pharmacy staff in approximately 60 community/retail pharmacies. The 
purpose of the pretest is to collect data for an assessment of the 
reliability and construct validity of the survey's items and 
composites, allowing for their further refinement.
    (3) Pharmacy background questionnaire--This questionnaire will be 
completed by the pharmacy manager in each of the 60 pretest sites to 
provide background characteristics of the pharmacy, such as pharmacy 
type (independently owned or chain), type of chain (traditional 
drugstore, supermarkets, mass merchant), average number of 
prescriptions filled weekly, average number of hours the pharmacy is 
open on weekdays, etc.
    (4) Dissemination activities--The final questionnaire will be made 
available to the public through the AHRQ website. This activity does 
not impose a burden on the public and is therefore not included in the 
burden estimates in Exhibit 1.
    The information collected will be used to test and improve the 
draft survey items in the Pharmacy Survey on Patient Safety Culture 
Questionnaire. Psychometric analysis will be conducted on the pilot 
data to examine item nonresponse, item response variability, factor 
structure, reliability, and construct validity of the items included in 
the survey. Because the survey items are being developed to measure 
specific aspects of patient safety culture in the pharmacy setting, the 
factor structure of the survey items will be evaluated through 
multilevel confirmatory factor analysis. On the basis of the data 
analyses, items or factors may be dropped.

Estimated Annual Respondent Burden

    Exhibit 1 shows the estimated annualized burden hours for the 
pharmacies' time to participate in this research. Cognitive interviews 
will be conducted with staff at 20 pharmacies (approximately 10 
pharmacists and 10 nonpharmacist staff) and will take about one hour 
and 30 minutes to complete. 627 staff from 60 pharmacies will 
participate in the pretest (an average of 10.45 staff from each 
pharmacy). The pretest questionnaire (the Pharmacy Survey on Patient 
Safety Culture) requires 15 minutes to complete. The pharmacy 
background questionnaire will be completed by the manager at each of 
the 60 pharmacies participating in the pretest and takes 10 minutes to 
complete. The total annualized burden is estimated to be 197 hours.
    Exhibit 2 shows the estimated annualized cost burden associated 
with the pharmacies' time to participate in this research. The total 
cost burden is estimated to be $4,948 annually.

                                  Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of
               Form Name/activity                    Number of    responses  per     Hours per     Total burden
                                                    pharmacies       pharmacy        response          hours
----------------------------------------------------------------------------------------------------------------
Cognitive interviews............................              20               1             1.5              30
Pretest.........................................              60           10.45           15/60             157
Pharmacy background questionnaire...............              60               1           10/60              10
                                                 ---------------------------------------------------------------
    Total.......................................             140              na              na             197
----------------------------------------------------------------------------------------------------------------


[[Page 30174]]


                                   Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
                                                     Number of     Total burden   Average hourly    Total cost
               Form Name/activity                   pharmacies         hours        wage rate *       burden
----------------------------------------------------------------------------------------------------------------
Cognitive interviews............................              20              30          $32.28            $968
Pretest.........................................              60             157           22.08           3,467
Pharmacy background questionnaire...............              60              10           51.27             513
                                                 ---------------------------------------------------------------
    Total.......................................             140             197              na          $4,948
----------------------------------------------------------------------------------------------------------------
* Based upon the mean of the average hourly wages for Pharmacists (29-1051; $51.27), Pharmacy Technicians (29-
  2052; $13.92), and Pharmacy Aides (31-9095; $10.74), National Compensation Survey: Occupational wages in the
  United States May 2009, ``U.S. Department of Labor, Bureau of Labor Statistics.'' The hourly wage for the
  cognitive interviews is a weighted average for 10 pharmacists, 8 pharmacy technicians and 2 pharmacy aides;
  the hourly wage for the pretest is a weighted average for 157 pharmacists, 235 pharmacy technicians and 235
  pharmacy aides.

Estimated Annual Costs to the Federal Government

    Exhibit 3 shows the estimated total and annualized cost for this 
project. Although data collection will last for less than one year, the 
entire project will take about 3 years. The total cost for this project 
is approximately $320,818.

             Exhibit 3--Estimated Total and Annualized Cost
------------------------------------------------------------------------
                                                            Annualized
             Cost component                 Total cost         cost
------------------------------------------------------------------------
Project Development.....................         $65,340         $21,780
Data Collection Activities..............          62,831          20,944
Data Processing and Analysis............          11,004           3,368
Publication of Results..................          15,767           5,256
Project Management......................           7,496           2,498
Overhead................................         158,380           5,293
                                         -------------------------------
    Total...............................         320,818         106,939
------------------------------------------------------------------------

Request for Comments

    In accordance with the Paperwork Reduction Act, comments on AHRQ's 
information collection are requested with regard to any of the 
following: 0(a) Whether the proposed collection of information is 
necessary for the proper performance of AHRQ healthcare research and 
healthcare information dissemination functions, including whether the 
information will have practical utility; (b) the accuracy of AHRQ's 
estimate of burden (including hours and costs) of the proposed 
collection(s) of information; (c) ways to enhance the quality, utility, 
and clarity of the information to be collected; and (d) ways to 
minimize the burden of the collection of information upon the 
respondents, including the use of automated collection techniques or 
other forms of information technology.
    Comments submitted in response to this notice will be summarized 
and included in the Agency's subsequent request for OMB approval of the 
proposed information collection. All comments will become a matter of 
public record.

    Dated: May 10, 2011.
Carolyn M. Clancy,
Director.
[FR Doc. 2011-12505 Filed 5-23-11; 8:45 am]
BILLING CODE 4160-90-M